Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor.
about
Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factorMolecular characterization of a gene of the 'EGF family' expressed in undifferentiated human NTERA2 teratocarcinoma cellsFourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancerRoles of Proteoglycans and Glycosaminoglycans in Wound Healing and FibrosisExpression and characterization of transforming growth factor alpha precursor protein in transfected mammalian cellsSchwannoma-derived growth factor promotes the neuronal differentiation and survival of PC12 cellsDistribution of epidermal growth factor receptor and ligands during bronchiolar epithelial repair from naphthalene-induced Clara cell injury in the mouseAngiogenic growth factors in neural embryogenesis and neoplasiaIsolation of genomic sequence encoding a biologically active bovine TGF-alpha protein.Human epidermal growth factor for the stratification of synovial lining layer and neovascularisation in rheumatoid arthritis.Preimplantation embryo development in vitro: cooperative interactions among embryos and role of growth factorsEndothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation.Current therapies for wound healing: electrical stimulation, biological therapeutics, and the potential for gene therapy.Factors promoting tumor angiogenesis.Platelet-derived growth factor synthesis in mesangial cells: induction by multiple peptide mitogensSomatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase.Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers.From wavy hair to naked proteins: the role of transforming growth factor alpha in health and disease.Transforming growth factor beta1 (TGF-beta1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-alpha signalingGrowth of the chick area vasculosa in ovo and in shell-less cultureAngiogenin-mediated ribosomal RNA transcription as a molecular target for treatment of head and neck squamous cell carcinoma.Induction of vascular endothelial tubular morphogenesis by human glioma cells. A model system for tumor angiogenesis.Targeting the EGFR signaling pathway in cancer therapy.Screening for candidate hepatic growth factors by selective portal infusion after canine Eck's fistula.Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesisProduction of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycleTransforming growth factor-alpha in vivo stimulates epithelial cell proliferation in digestive tissues of suckling ratsEpidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiologyOpposite effects of transforming growth factor alpha and epidermal growth factor on mouse placental lactogen I secretion.The human transforming growth factor type alpha coding sequence is not a direct-acting oncogene when overexpressed in NIH 3T3 cellsZD1839 (IRESSA): a selective EGFR-TK inhibitor.Fibromodulin Enhances Angiogenesis during Cutaneous Wound Healing.The influence of tethered epidermal growth factor on connective tissue progenitor colony formation.Genetically engineered mice as experimental tools to dissect the critical events in breast cancerLocalization of the human angiogenin gene to chromosome band 14q11, proximal to the T cell receptor alpha/delta locusRoles for transforming growth factor-alpha in gastric physiology and pathophysiologyFactors controlling pancreatic islet neogenesis.Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implicationsNovel chemotherapeutic and targeted agents in metastatic colorectal cancer: the time has arrived.Suramin, an experimental chemotherapeutic drug, activates the receptor for epidermal growth factor and promotes growth of certain malignant cells.
P2860
Q24560244-32A1EC83-CF16-446A-89F3-BAFC2B34F56DQ24567485-DB514287-1254-4A4B-A30E-A92084929BE9Q24685693-4CE53001-C6D6-4C4C-BD6C-88C28EC980DCQ26786042-6E4B40B7-EE6C-4FD7-AEED-FC3CE8618031Q28574332-78C9531F-AABB-490B-8C45-68B9C84362C3Q28576415-13B4FC69-FA16-4F9A-9422-9265842768EDQ28762835-84F30A2D-C6E5-4257-BCC9-A35A2A0AABBDQ30498863-802ECA5A-66B8-4BED-892D-DC344C9D0D2BQ33259160-0E1E023B-6A4D-4E9D-884D-11318CD3F14EQ33562073-A6C21B7F-69CF-4840-A4BE-66D5825826AAQ33643182-83E0B385-1BC3-44C8-AACA-2F5F1679FCA3Q33656940-CA655EBC-6F2B-4DB6-AE18-4EA1A306151DQ33785792-D25C7830-E69D-47CF-AAF3-DBFA9A99A8E4Q33791689-9A375BA0-87C6-4F4E-918C-D681D3B41DF6Q33836105-1706FFA4-F421-47C9-B16A-81B8270EF2D7Q33844684-95EC7D88-D7BB-443F-AA04-27E57D495205Q33888963-84BB13A3-72E7-4599-BB64-5BD9A5A5A523Q33926726-0DB47547-8D75-42AC-B33E-D15E9F015A3FQ34012586-D7ABED24-1103-443E-BF54-9B84DFF252DBQ34083801-B557A289-D16B-46F0-8A57-13EB6D60DB27Q34101582-4534D200-BE12-4369-BEBA-043B5F2FD01AQ34109863-577B6A5F-E57F-4095-95F1-D1A9182336BFQ34246558-C30516D7-C1CC-48ED-813D-C7D031BED4AFQ34289259-3D9257FC-EE26-4810-A63A-86C84D9C88FFQ34325744-D6CABAA4-0207-43DC-8718-FBF5BE891DC5Q34359163-955BD02B-D768-4403-B525-2AB126D5C9A4Q34410059-5DFF7BAC-8E39-4272-9798-D4A8129785F6Q34435505-530F0267-AA0F-491D-A334-D6049E1E2315Q34507075-A3239418-45E8-48B6-9E7A-12A6D6DA5C24Q34627570-50FA6189-7163-4542-9218-DC713477BB6CQ34734513-946C45FA-3BC7-4C0C-9126-B36343D54ED9Q34932131-47A0A912-0758-40E4-A72C-4A9E314ABFF4Q35057867-D7ABF576-2990-47CF-A030-3BA0E7FB0174Q35146602-3F08F630-F485-4968-8C17-89F152B9C792Q35198537-56AE1BEC-DB93-4005-9291-1B571F474D47Q35242603-F926DD1A-2D1C-4130-AFC4-C6DC87BF5F8FQ35279852-9C43DCD7-A5CB-4B39-8867-2E44BFAA5250Q35327839-4F99EC9B-DE43-4FF3-8C24-420921CB0FE3Q35594038-0F5E1C87-23C2-4135-A8EE-BBF8DA5630C2Q35600805-1E99A23D-A89D-49EE-B502-F2262B770E54
P2860
Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh-hant
name
Transforming growth factor-alp ...... than epidermal growth factor.
@en
Transforming growth factor-alp ...... than epidermal growth factor.
@nl
type
label
Transforming growth factor-alp ...... than epidermal growth factor.
@en
Transforming growth factor-alp ...... than epidermal growth factor.
@nl
prefLabel
Transforming growth factor-alp ...... than epidermal growth factor.
@en
Transforming growth factor-alp ...... than epidermal growth factor.
@nl
P2093
P356
P1433
P1476
Transforming growth factor-alp ...... than epidermal growth factor.
@en
P2093
Schreiber AB
Winkler ME
P304
P356
10.1126/SCIENCE.2422759
P407
P577
1986-06-01T00:00:00Z